• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

Evaluation Of Safety And Efficacy Of Vitamin D Supplementation Inerectile Dysfunction Patients With Vitamin D Deficiency

    Dr. Anwar Ali, Dr. Prasant Ranjan, Dr. Shivam Priyadarshi, Dr. Ravi Pandey

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 225-230

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: To evaluate the safety and efficacy of Vitamin D supplementation in erectile dysfunction patients with Vitamin D deficiency.
 
Material and Method: This study was carried out in Department of Urology, S.M.S. Medical College and attached Hospitals between March 2018 to April 2019 among patients in the age group 20-60 years presenting with ED and having severe Vitamin D deficiency. Patients were randomized into three groups. First group was treated with Tadalafil 10mg once a day while the second group had Tadalafil 10mg once a day plus Vitamin D 60,000 IU once a week, and third group was given Vitamin D 60,000 IU once a week only. Efficacy of drugs was evaluated at base line and after 12 weeks on the basis of International Index of Erectile Function Questionnaire scoring.
 
Results: After 12 weeks of treatment IIEF-5 scoring was nearly same as that of the base line with no significant difference in group C patients. On the other hand, IIEF-5 scoring was significantly improved in group A and B patients (P<0.001). On comparing group A and B patients there was significant improvement in group B compared to group A (P < 0.05). In comparison to group C, group A and group B patients had more side effects (P<0.05), but of mild intensity and prescribed medications were well tolerated. Group A and B patients had no significant difference in side effects.
 
Conclusion: This study showed that the use of Tadalafil in combination with Vitamin D in Vit D deficient ED patients act better than Tadalafil or Vit. D alone.
 
Keyword: ED, Vitamin D, Tadalafil, IIEF
Keywords:
  • PDF (183 K)
  • XML
(2021). Evaluation Of Safety And Efficacy Of Vitamin D Supplementation Inerectile Dysfunction Patients With Vitamin D Deficiency. European Journal of Molecular & Clinical Medicine, 8(4), 225-230.
Dr. Anwar Ali, Dr. Prasant Ranjan, Dr. Shivam Priyadarshi, Dr. Ravi Pandey. "Evaluation Of Safety And Efficacy Of Vitamin D Supplementation Inerectile Dysfunction Patients With Vitamin D Deficiency". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 225-230.
(2021). 'Evaluation Of Safety And Efficacy Of Vitamin D Supplementation Inerectile Dysfunction Patients With Vitamin D Deficiency', European Journal of Molecular & Clinical Medicine, 8(4), pp. 225-230.
Evaluation Of Safety And Efficacy Of Vitamin D Supplementation Inerectile Dysfunction Patients With Vitamin D Deficiency. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 225-230.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 185
  • PDF Download: 333
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus